TREA

79280749 - OXYGENE

Follow

Information

  • Trademark
  • 79280749
  • Serial Number
    79280749
  • Registration Number
    6541534
  • Filing Date
    January 15, 2020
    5 years ago
  • Registration Date
    November 02, 2021
    3 years ago
  • Transaction Date
    May 04, 2024
    8 months ago
  • Status Date
    November 02, 2021
    3 years ago
  • Published for Opposition Date
    August 17, 2021
    3 years ago
  • Location Date
    November 02, 2021
    3 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BARAHONA, BYRON
  • Attorney Docket Number
    8674-200264
    Attorney Name
    Monte L. Falcoff/Jessica S. Sachs
    Law Office Assigned Location Code
    N90
  • Owners
Information
Mark Drawing Code
4
Mark Identification
OXYGENE
Case File Statements
  • GS0401: Supply in the nature of custom manufacture of production units for biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; contract manufacturing for others of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; production in the nature of custom manufacture of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; none of the foregoing in the field of cancer research or for cancer therapies or vascular targeting agents
  • PM0001: OXYGEN
  • GS0421: Study in the nature of conducting scientific feasibility studies and design of production factories and buildings; inspection of production factories and buildings for quality control and consultancy purposes; engineering; preparation of technical studies; quality control of production units in the pharmaceutical and biopharmaceutical field with a view to certification; research and development of new products for third parties; technological services regarding manufacture of biological molecules, particularly viral vectors and monoclonal antibodies, in the pharmaceutical and biopharmaceutical field; none of the foregoing in the field of cancer research or for cancer therapies or vascular targeting agents
Case File Event Statements
  • 4/1/2020 - 4 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/12/2020 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 3/13/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/17/2020 - 4 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 4/10/2020 - 4 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/11/2020 - 4 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 7/14/2020 - 4 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/28/2020 - 4 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 4/28/2020 - 4 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 5/15/2020 - 4 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 7/14/2020 - 4 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/14/2020 - 4 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/20/2020 - 4 years ago
    14 - FINAL REFUSAL E-MAILED Type: GNFR
  • 7/20/2020 - 4 years ago
    13 - FINAL REFUSAL WRITTEN Type: CNFR
  • 7/20/2020 - 4 years ago
    15 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 10/26/2020 - 4 years ago
    16 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 10/26/2020 - 4 years ago
    17 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/26/2020 - 4 years ago
    18 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/19/2021 - 3 years ago
    19 - EXPARTE APPEAL RECEIVED AT TTAB Type: EXAF
  • 1/19/2021 - 3 years ago
    20 - JURISDICTION RESTORED TO EXAMINING ATTORNEY Type: JURT
  • 1/19/2021 - 3 years ago
    21 - EX PARTE APPEAL-INSTITUTED Type: EXPI
  • 1/19/2021 - 3 years ago
    22 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 1/26/2021 - 3 years ago
    25 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 1/26/2021 - 3 years ago
    23 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 1/26/2021 - 3 years ago
    24 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 4/3/2021 - 3 years ago
    27 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 4/6/2021 - 3 years ago
    28 - CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: CORN
  • 4/9/2021 - 3 years ago
    29 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/10/2021 - 3 years ago
    30 - CHANGE OF OWNER RECEIVED FROM IB Type: CHLD
  • 7/13/2021 - 3 years ago
    33 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/5/2021 - 3 years ago
    26 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/25/2021 - 3 years ago
    31 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 7/9/2021 - 3 years ago
    32 - ASSIGNED TO LIE Type: ALIE
  • 7/13/2021 - 3 years ago
    34 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/14/2021 - 3 years ago
    35 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/28/2021 - 3 years ago
    38 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 8/17/2021 - 3 years ago
    40 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/28/2021 - 3 years ago
    36 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/28/2021 - 3 years ago
    37 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 8/14/2021 - 3 years ago
    39 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 8/17/2021 - 3 years ago
    41 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/23/2021 - 3 years ago
    42 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/2/2021 - 3 years ago
    43 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/21/2022 - 2 years ago
    45 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 2/2/2022 - 2 years ago
    44 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/21/2022 - 2 years ago
    46 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 5/4/2024 - 8 months ago
    48 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 5/15/2022 - 2 years ago
    47 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO